# PMPCA

## Overview
The PMPCA gene encodes the mitochondrial processing peptidase subunit alpha (α-MPP), a critical component of the mitochondrial processing peptidase (MPP) complex. This complex is essential for the maturation of mitochondrial precursor proteins by cleaving their targeting sequences, thereby facilitating their proper folding and function within the mitochondria. The α-MPP, categorized as a peptidase, plays a pivotal role in substrate recognition and transfer to the catalytic site of the beta subunit, PMPCB, ensuring precise processing of mitochondrial proteins. This function is vital for maintaining mitochondrial integrity and cellular metabolism. Mutations in the PMPCA gene can lead to various mitochondrial disorders, highlighting its clinical significance in human health (Joshi2016Mutations; Serpieri2021Phenotypic; Gakh2002Mitochondrial).

## Structure
The PMPCA gene encodes the alpha subunit of the mitochondrial processing peptidase (MPP), a crucial enzyme for cleaving mitochondrial targeting sequences from precursor proteins. The primary structure of PMPCA includes a sequence of amino acids that form specific domains essential for its function. A key structural element is the glycine-rich loop (GRL, residues 345-358), which is vital for substrate recognition and binding, facilitating the movement of precursor proteins toward the active site (Joshi2016Mutations; Serpieri2021Phenotypic).

The secondary structure of PMPCA includes alpha helices and beta sheets, contributing to its stability and function. The tertiary structure involves the 3D folding of the protein, which is necessary for its interaction with substrates and other proteins. In terms of quaternary structure, PMPCA forms a heterodimer with the beta subunit of MPP, which is essential for its enzymatic activity (Gakh2002Mitochondrial).

Post-translational modifications such as phosphorylation and acetylation may occur, influencing the protein's function and stability. These structural features and modifications are critical for the proper processing of mitochondrial proteins and the maintenance of mitochondrial function (Gakh2002Mitochondrial).

## Function
The PMPCA gene encodes the α-mitochondrial processing peptidase (α-MPP), a subunit of the mitochondrial processing peptidase (MPP) complex, which is essential for the maturation of mitochondrial precursor proteins. In healthy human cells, most mitochondrial proteins are synthesized in the cytosol as precursors with amino-terminal extensions known as targeting peptides (TPs). These TPs are cleaved by the MPP complex upon import into the mitochondria, allowing the proteins to fold and mature properly (Joshi2016Mutations; PovedaHuertes2016The).

The MPP complex is a heterodimer composed of PMPCA and PMPCB subunits. While PMPCB is primarily responsible for the catalytic activity, PMPCA plays a crucial role in substrate recognition. It facilitates the transfer of precursor proteins to the active site of PMPCB, ensuring precise cleavage of the targeting sequences (Gomez‐Fabra2021Mitochondrial; Quirós2015New). This process is vital for mitochondrial protein biogenesis, quality control, and overall mitochondrial integrity, impacting cellular metabolism and energy production (PovedaHuertes2016The; Quirós2015New).

Proper functioning of PMPCA is essential for maintaining mitochondrial function and cellular health, as it ensures the correct processing and localization of mitochondrial proteins (Gakh2002Mitochondrial).

## Clinical Significance
Mutations in the PMPCA gene, which encodes the mitochondrial processing peptidase subunit alpha, are linked to a range of mitochondrial diseases. These mutations can lead to severe mitochondrial encephalopathy with multiorgan involvement, characterized by symptoms such as profound psychomotor delay, ptosis, ophthalmoplegia, hypotonia, severe generalized weakness, optic atrophy, cardiomyopathy, liver failure, and global brain atrophy (Serpieri2021Phenotypic). 

PMPCA mutations are also associated with autosomal recessive spinocerebellar ataxia type 2 (SCAR2), a condition marked by cerebellar atrophy, developmental delay, and intellectual disability (Serpieri2021Phenotypic; Takahashi2021A). In some cases, these mutations result in a severe phenotype with progressive neurological symptoms, including ataxia and rigidity, and MRI findings of cerebellar atrophy and brain iron accumulation (Takahashi2021A).

Additionally, PMPCA mutations can cause late-onset dominant optic atrophy, a mitochondrial disease leading to blindness. This condition is linked to alterations in the mitochondrial network's fusion-fission balance, crucial for retinal ganglion cell physiology (Charif2022NextGeneration). The clinical significance of PMPCA mutations is underscored by their impact on mitochondrial protein processing, which can lead to multisystemic disorders (Joshi2016Mutations).

## Interactions
The PMPCA gene encodes the alpha subunit of the mitochondrial processing peptidase (MPP), which forms a heterodimeric complex with the beta subunit, PMPCB. This complex is crucial for the cleavage of mitochondrial targeting sequences from precursor proteins, facilitating their maturation and proper function within the mitochondria (Antonicka2020A; Serpieri2021Phenotypic). The interaction between PMPCA and PMPCB is essential for the activity of the MPP complex, as these two proteins work together to process mitochondrial proteins (Antonicka2020A).

Mutations in PMPCA can disrupt its interaction with PMPCB, leading to impaired processing of mitochondrial proteins such as frataxin, which is associated with mitochondrial diseases like Friedreich's ataxia (Joshi2016Mutations). The glycine-rich loop of PMPCA is particularly important for substrate binding and catalytic activity, and mutations in this region can alter the conformation and flexibility of the loop, affecting the enzyme's function (Joshi2016Mutations).

Additionally, PMPCA has been identified as a potential target of staurosporine, a pan-specific protein kinase inhibitor, suggesting it may participate in broader protein-protein interactions beyond its role in the MPP complex (Zhang2022Highly).


## References


[1. (Joshi2016Mutations) Mugdha Joshi, Irina Anselm, Jiahai Shi, Tejus A. Bale, Meghan Towne, Klaus Schmitz-Abe, Laura Crowley, Felix C. Giani, Shideh Kazerounian, Kyriacos Markianos, Hart G. Lidov, Rebecca Folkerth, Vijay G. Sankaran, and Pankaj B. Agrawal. Mutations in the substrate binding glycine-rich loop of the mitochondrial processing peptidase-α protein (pmpca) cause a severe mitochondrial disease. Molecular Case Studies, 2(3):a000786, February 2016. URL: http://dx.doi.org/10.1101/mcs.a000786, doi:10.1101/mcs.a000786. This article has 33 citations.](https://doi.org/10.1101/mcs.a000786)

[2. (Takahashi2021A) Yoko Takahashi, Masaya Kubota, Rika Kosaki, Kenjiro Kosaki, and Akira Ishiguro. A severe form of autosomal recessive spinocerebellar ataxia associated with novel pmpca variants. Brain and Development, 43(3):464–469, March 2021. URL: http://dx.doi.org/10.1016/j.braindev.2020.11.008, doi:10.1016/j.braindev.2020.11.008. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.braindev.2020.11.008)

[3. (Gakh2002Mitochondrial) Oleksandr Gakh, Patrizia Cavadini, and Grazia Isaya. Mitochondrial processing peptidases. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1592(1):63–77, September 2002. URL: http://dx.doi.org/10.1016/s0167-4889(02)00265-3, doi:10.1016/s0167-4889(02)00265-3. This article has 343 citations.](https://doi.org/10.1016/s0167-4889(02)00265-3)

[4. (Quirós2015New) Pedro M. Quirós, Thomas Langer, and Carlos López-Otín. New roles for mitochondrial proteases in health, ageing and disease. Nature Reviews Molecular Cell Biology, 16(6):345–359, May 2015. URL: http://dx.doi.org/10.1038/nrm3984, doi:10.1038/nrm3984. This article has 440 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrm3984)

[5. (Gomez‐Fabra2021Mitochondrial) Maria Gomez‐Fabra Gala and Friederike‐Nora Vögtle. Mitochondrial proteases in human diseases. FEBS Letters, 595(8):1205–1222, February 2021. URL: http://dx.doi.org/10.1002/1873-3468.14039, doi:10.1002/1873-3468.14039. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/1873-3468.14039)

6. (Antonicka2020A) A high-density human mitochondrial proximity interaction network. This article has 4 citations.

[7. (Charif2022NextGeneration) Majida Charif, Arnaud Chevrollier, Naïg Gueguen, Selma Kane, Céline Bris, David Goudenège, Valerie Desquiret-Dumas, Isabelle Meunier, Fanny Mochel, Luc Jeanjean, Fanny Varenne, Vincent Procaccio, Pascal Reynier, Dominique Bonneau, Patrizia Amati-Bonneau, and Guy Lenaers. Next-generation sequencing identifies novel pmpca variants in patients with late-onset dominant optic atrophy. Genes, 13(7):1202, July 2022. URL: http://dx.doi.org/10.3390/genes13071202, doi:10.3390/genes13071202. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13071202)

[8. (Zhang2022Highly) Xiaolei Zhang, Keyun Wang, Sijin Wu, Chengfei Ruan, Kejia Li, Yan Wang, He Zhu, Xiaoyan Liu, Zhen Liu, Guohui Li, Lianghai Hu, and Mingliang Ye. Highly effective identification of drug targets at the proteome level by ph-dependent protein precipitation. Chemical Science, 13(42):12403–12418, 2022. URL: http://dx.doi.org/10.1039/d2sc03326g, doi:10.1039/d2sc03326g. This article has 9 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1039/d2sc03326g)

[9. (Serpieri2021Phenotypic) Valentina Serpieri, Tommaso Biagini, Concetta Mazzotta, Rosa Pasquariello, Anna Rubegni, Filippo Santorelli, Gerardo Ongari, Silvia Cerri, Tommaso Mazza, Roberta Battini, and Enza Maria Valente. Phenotypic definition and genotype-phenotype correlates in pmpca-related disease. Applied Sciences, 11(2):748, January 2021. URL: http://dx.doi.org/10.3390/APP11020748, doi:10.3390/app11020748. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/APP11020748)

[10. (PovedaHuertes2016The) Daniel Poveda-Huertes, Patrycja Mulica, and F. Nora Vögtle. The versatility of the mitochondrial presequence processing machinery: cleavage, quality control and turnover. Cell and Tissue Research, 367(1):73–81, September 2016. URL: http://dx.doi.org/10.1007/s00441-016-2492-9, doi:10.1007/s00441-016-2492-9. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00441-016-2492-9)